ISCO Projected Dividend Yield
International Stem Cell Corp ( OTCBB : ISCO )International Stem Cell is a clinical stage biotechnology company focused on therapeutic and biomedical product development. Co. is developing different cell types from its stem cells that may result in therapeutic products. Co.'s subsidiary, Lifeline Skin Care, Inc., develops, manufactures and markets a line of skincare products with anti-aging benefits that is based on Co.'s proprietary human non-embryonic stem cell extract and targeted molecule technologies. Co.'s other subsidiary, Lifeline Cell Technology, LLC, develops, manufactures and commercializes human cell culture products, including frozen human primary cells and the reagents needed to grow, maintain and differentiate the cells. 20 YEAR PERFORMANCE RESULTS |
ISCO Dividend History Detail ISCO Dividend News ISCO Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |